Podcast

Margo Minissian, PhD, ACNP, on Non-Statin Therapies for Lowering Cholesterol

07/16/2018

 

 

Margo Minissian, PhD, ACNP, from the Cedars-Sinai Heart Institute discusses her session about non-statin therapies for lowering cholesterol, which she will be presenting at Consultant's Cardiometabolic Risk Summit.

Margo Minissian, PhD, ACNP, is a nurse scientist, cardiology nurse practitioner, and clinical lipid specialist at the Barbra Streisand Women's Heart Center at the Cedars-Sinai Smidt Heart Institute in Los Angeles, California.

To register for Consultant's Cardiometabolic Risk Summit, click here.

For more CRS 2018 conference coverage, click here.

 

ADDITIONAL RESOURCES:

Goff DC, Lloyd-Jones DM, Bennett G, et al; ACCF/AHA Task Force. 2013 ACC/AHA guideline on the assessment of cardiovascular risk [published online November 13, 2013]. Circulation. https://doi.org/10.1161/01.cir.0000437741.48606.98. 

ASCVD Risk Estimator Plus. American College of Cardiology. http://tools.acc.org/ascvd-risk-estimator-plus/#!/calculate/estimate/. 

Stone NJ, Robinson JG, Lichtenstein AH, et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Cardiol Coll. 2014;63(25, part B):2889-2934. doi:10.1016/j.jacc.2013.11.002.

Sabatine MS, Giugliano RP, Keech, et al; FOURIER Steering Committee and Investigators. Evolocumab and clinical outcomes in patients
with cardiovascular disease. N Engl J Med. 2017;376(18):1713-1722. doi:10.1056/NEJMoa1615664.

Lloyd-Jones DM, Morris PB, Ballantyne CM, et al; American College of Cardiology Task Force on Expert Consensus Decision Pathways. 2017 focused update of the 2016 ACC expert consensus decision pathway on the role of non-statin therapies for LDL-cholesterol lowering in the management of atherosclerotic cardiovascular disease [published online September 5, 2017]. J Am Coll Cardiol. doi:10.1016/j.jacc.2017.07.745.

Related Content

asthma
asthma
Shervin S. Takyar, MD, PhD, on the Regulation of Endothelial MicroRNA-1 in Asthma
03/30/2022
In this podcast, Shervin S. Takyar, MD, PhD, from Yale School of Medicine, answers our questions about how microRNA-1 regulates eosinophil trafficking in patients with asthma and chronic...
03/30/2022
Endocrine Disorders
Endocrine Disorders
Jeffrey Levine, MD: PCOS, CVD Risk, and the Role of Primary Care
09/26/2019
In this podcast, Dr Levine discusses the diagnosis of PCOS in the primary care setting, addressing associated cardiovascular risks, and the 5 main goals of treatment.
09/26/2019
HIV Management
HIV Management
Barriers to ART Adherence Post-Incarceration
08/26/2022
In this podcast, Tawandra Rowell-Cunsolo, PhD, discusses her recent study, which identified 4 barriers to optimal antiretroviral therapy adherence among individuals with HIV who were formerly incarcerated,...
08/26/2022
Practice Management
Practice Management
Eileen O'Grady, PhD, RN, NP, on The Burnout Epidemic
09/23/2020
In this podcast, Eileen O'Grady, PhD, RN, NP, discusses provider burnout, contributing factors such as electronic medical records, and current initiatives geared toward combating the burnout epidemic.
09/23/2020
Kidney Failure
Kidney Failure
James Matera, MD, on Treating Hep C in ESRD, Renal Transplant Candidates
11/21/2018
James Matera, DO, details advances in the treatment of hepatitis C virus in patients with end-stage renal disease. He also explains why it may be beneficial to defer hepatitis C treatment until after renal...
11/21/2018